6533b7d1fe1ef96bd125cd55
RESEARCH PRODUCT
Results of COLUMBUS Part 2: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus ENCO in BRAF-mutant melanoma
L.a. De ParsevalV. SandorC. RobertRalf GutzmerClaus GarbeV. Chiarion SileniNaoya YamazakiMichael D PickardCarmen LoquaiP.a. AsciertoJ.w.b. De GrootAna AranceMario MandalàReinhard DummerGabriella LiszkayC. DutriauxKeith T. FlahertyHelen GogasIvana KrajsováDirk Schadendorfsubject
0301 basic medicinebusiness.industryMelanomaMutantBinimetinibHematologymedicine.disease03 medical and health scienceschemistry.chemical_compound030104 developmental biology0302 clinical medicineOncologychemistry030220 oncology & carcinogenesisEncorafenibmedicineCancer researchbusinessyear | journal | country | edition | language |
---|---|---|---|---|
2017-09-01 |